Scientists test new 'Slow-Release' hormone drug in healthy volunteers
NCT ID NCT06315205
Summary
This early-stage study is testing a new, long-acting injectable version of the drug letrozole in healthy post-menopausal women. The main goal is to understand how the body processes the drug and to check if it is safe and well-tolerated. Researchers will give single injections at different doses to about 90 volunteers to gather this initial information.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigational Site number CZ-01
Prague, Czechia
Conditions
Explore the condition pages connected to this study.